Comparing Lower Versus Standard Doses of Belantamab Mafodotin With Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma.
Clinical trial NCT07748689 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07748689
- Sponsor
- Polish Myeloma Consortium
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2033-03-01
- Enrollment
- 228
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.